BLOOD-PRESSURE BEHAVIOR IN PATIENTS ON CHRONIC-HEMODIALYSIS (CH) TREATED WITH SUBCUTANEOUS AND ENDOVENOUS (EV) ERYTHROPOIETIN (EPO)

被引：0
作者：
AMAYA, L [1 ]
BONELLI, CA [1 ]
PEREZ, N [1 ]
CHAMORRO, A [1 ]
OLMOS, Z [1 ]
BRUSCO, P [1 ]
VELAZQUEZ, J [1 ]
GUITIAN, N [1 ]
CASTRO, I [1 ]
机构：
[1] CENT MIL HOSP, BUENOS AIRES, ARGENTINA
来源：
KIDNEY INTERNATIONAL | 1993年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1413 / 1413
页数：1
相关论文
共 50 条
[41]   CHANGES IN BLOOD RHEOLOGY OF ANEMIC HEMODIALYSIS (HD) PATIENTS TREATED WITH RECOMBINANT HUMAN ERYTHROPOIETIN (EPO) [J].
BALDAMUS, CA ;
POLLOK, M ;
BRUNNER, R ;
STEFFEN, HM .
KIDNEY INTERNATIONAL, 1990, 37 (01) :271-271
[42]   RECOMBINANT HUMAN ERYTHROPOIETIN (EPO) AND PHLEBOTOMY (PLB) IN THE TREATMENT OF IRON OVERLOAD (IO) IN CHRONIC-HEMODIALYSIS (HD) PATIENTS (PTS) [J].
LAZARUS, JM ;
HAKIM, RM ;
NEWELL, J ;
MAIGA, M .
KIDNEY INTERNATIONAL, 1989, 35 (01) :253-253
[43]   BRAIN-FUNCTION IMPROVES IN CHRONIC-HEMODIALYSIS (CHD) PATIENTS (PTS) AFTER RECOMBINANT ERYTHROPOIETIN (R-EPO) [J].
NISSENSON, AR ;
MARSH, JT ;
BROWN, WS ;
SCHWEITZER, S ;
WOLCOTT, DL .
KIDNEY INTERNATIONAL, 1989, 35 (01) :257-257
[44]   IMPORTANCE OF THE ADMINISTRATION ROUTE OF ERYTHROPOIETIN IN BLOOD-PRESSURE CONTROL IN HEMODIALYSIS-PATIENTS [J].
TERUEL, J ;
NAVARRO, J ;
PASCUAL, J ;
GAMEZ, C ;
LIANO, F ;
MARCEN, R ;
ORTUNO, J .
KIDNEY INTERNATIONAL, 1993, 44 (06) :1480-1480
[45]   THE EFFECT OF RECOMBINANT HUMAN ERYTHROPOIETIN (EPO) UPON QUALITY OF LIFE AND FUNCTIONAL-CAPACITY OF ANEMIC PATIENTS ON CHRONIC-HEMODIALYSIS [J].
LAUPACIS, A .
CLINICAL RESEARCH, 1989, 37 (02) :A318-A318
[46]   EFFECTS OF HEMODIALYSIS AND SALINE LOADING ON BODY-FLUID COMPARTMENTS, PLASMA-RENIN ACTIVITY AND BLOOD-PRESSURE IN PATIENTS ON CHRONIC-HEMODIALYSIS [J].
LEENEN, FHH ;
GALLA, SJ ;
GEYSKES, GG ;
MURDAUGH, HV ;
SHAPIRO, AP .
NEPHRON, 1977, 18 (02) :93-100
[47]   USE OF RED-BLOOD-CELL INDEXES (MCV, MCH, RDW) IN MONITORING CHRONIC-HEMODIALYSIS PATIENTS TREATED WITH RECOMBINANT ERYTHROPOIETIN [J].
FIALON, P ;
LEAUTE, AG ;
SASSIER, P ;
VALLOT, C ;
WONE, C .
PATHOLOGIE BIOLOGIE, 1993, 41 (10) :931-935
[48]   COMPARISON OF THE EFFICACY AND TOLERANCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN BETWEEN INTRAVENOUS AND SUBCUTANEOUS ROUTES IN CHRONIC-HEMODIALYSIS PATIENTS [J].
RUEDIN, P ;
STOERMAN, C ;
PECHEREBERTSCHI, A ;
LESKI, M .
NEPHROLOGIE, 1992, 13 (02) :87-92
[49]   THE INFLUENCE OF ACE-INHIBITION ON MYOCARDIAL MASS AND DIASTOLIC FUNCTION IN CHRONIC-HEMODIALYSIS PATIENTS WITH ADEQUATE CONTROL OF BLOOD-PRESSURE [J].
ROITHINGER, FX ;
PUNZENGRUBER, C ;
WALLNER, M ;
ULBRICH, W ;
PACHINGER, O ;
KRAMAR, R ;
PRISCHL, FC .
CLINICAL NEPHROLOGY, 1994, 42 (05) :309-314
[50]   EFFECT OF NORMAL V ANEMIC HEMATOCRIT ON AMBULATORY BLOOD-PRESSURE (ABP) IN ERYTHROPOIETIN-TREATED HEMODIALYSIS (HD) PATIENTS [J].
BERNS, JS ;
RUDNICK, MR ;
COHEN, RM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03) :520-520
12345